4th DFCI-Wyss Institute Joint Forum

Tuesday, September 17, 2013 at 5:00pm to 6:30pm

Interested in learning about engineering approaches to fight cancer? Looking for potential translational collaborators?


Dana-Farber Cancer Institute and the Wyss Institute for Biologically Inspired Engineering are leaders in innovative translational work and developing disruptive engineering solutions, respectively. We believe that you -- the scientists, physicians, and engineers who work in these Institutes to create novel therapeutics and interventions to improve the lives of patients -- will benefit from the opportunity to exchange ideas with one another and to build synergistic collaborations.


To foster this exciting community, a joint forum has been initiated. This forum is not simply a seminar series; rather, it is a pairing of talks (one from each Institute per session) that will be followed by comments from the Advanced Technology Team to explain potential paths for translation of the projects to the clinic. Such emphasis on translation is unique to this forum and is intended to help you to plan your research to maximize the likelihood of its broad application.


Because collaborations are often most successful when initiated by trainees, the talks will be given by trainees.


Food and beverages will be provided after the session to encourage networking.




"The (unkept) promise of targeted therapeutics: the rise of resistance to anti‐cancer drugs" – Cory Johannessen, Ph.D., The Broad Institute, Dana‐Farber Cancer Institute


“Studying human diseases using CRISPR/Cas and heart‐on‐chip technologies” – Luhan Yang, Ph.D., Harvard Medical School, Wyss Institute

Event Type

Clinical Research


Free of charge

Event Contact Name

Michael Goldberg, David Mooney & Ed Doherty

Event Contact Email

michael_goldberg1@dfci.harvard.edu, mooneyd@seas.harvard.edu, ed.doherty@wyss.harvard.edu

Recent Activity